Literature DB >> 25335803

Sodium-23 magnetic resonance imaging has potential for improving penumbra detection but not for estimating stroke onset time.

Friedrich Wetterling1, Lindsay Gallagher2, Jim Mullin2, William M Holmes2, Chris McCabe2, I Mhairi Macrae2, Andrew J Fagan3.   

Abstract

Tissue sodium concentration increases in irreversibly damaged (core) tissue following ischemic stroke and can potentially help to differentiate the core from the adjacent hypoperfused but viable penumbra. To test this, multinuclear hydrogen-1/sodium-23 magnetic resonance imaging (MRI) was used to measure the changing sodium signal and hydrogen-apparent diffusion coefficient (ADC) in the ischemic core and penumbra after rat middle cerebral artery occlusion (MCAO). Penumbra and core were defined from perfusion imaging and histologically defined irreversibly damaged tissue. The sodium signal in the core increased linearly with time, whereas the ADC rapidly decreased by >30% within 20 minutes of stroke onset, with very little change thereafter (0.5-6 hours after MCAO). Previous reports suggest that the time point at which tissue sodium signal starts to rise above normal (onset of elevated tissue sodium, OETS) represents stroke onset time (SOT). However, extrapolating core data back in time resulted in a delay of 72 ± 24 minutes in OETS compared with actual SOT. At the OETS in the core, penumbra sodium signal was significantly decreased (88 ± 6%, P=0.0008), whereas penumbra ADC was not significantly different (92 ± 18%, P=0.2) from contralateral tissue. In conclusion, reduced sodium-MRI signal may serve as a viability marker for penumbra detection and can complement hydrogen ADC and perfusion MRI in the time-independent assessment of tissue fate in acute stroke patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25335803      PMCID: PMC4294399          DOI: 10.1038/jcbfm.2014.174

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  32 in total

1.  Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia.

Authors:  Y Wang; W Hu; A D Perez-Trepichio; T C Ng; A J Furlan; A W Majors; S C Jones
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

2.  Assessment of myocardial viability by intracellular 23Na magnetic resonance imaging.

Authors:  Maurits A Jansen; Jan G Van Emous; Marcel G J Nederhoff; Cees J A Van Echteld
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

Review 3.  Measurement techniques for magnetic resonance imaging of fast relaxing nuclei.

Authors:  Simon Konstandin; Armin M Nagel
Journal:  MAGMA       Date:  2013-07-24       Impact factor: 2.310

4.  Regional and temporal variations in tissue sodium concentration during the acute stroke phase.

Authors:  Friedrich Wetterling; Lindsay Gallagher; I Mhairi Macrae; Sven Junge; Andrew J Fagan
Journal:  Magn Reson Med       Date:  2011-06-15       Impact factor: 4.668

5.  Comprehensive MR imaging protocol for stroke management: tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies.

Authors:  K R Thulborn; T S Gindin; D Davis; P Erb
Journal:  Radiology       Date:  1999-10       Impact factor: 11.105

6.  23Na nuclear magnetic resonance spectral changes during and after forebrain ischemia in hypoglycemic, normoglycemic, and hyperglycemic rats.

Authors:  R L Tyson; G R Sutherland; J Peeling
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

7.  Sodium MRI and the assessment of irreversible tissue damage during hyper-acute stroke.

Authors:  Fernando E Boada; Yongxian Qian; Edwin Nemoto; Tudor Jovin; Charles Jungreis; S C Jones; Jonathan Weimer; Vincent Lee
Journal:  Transl Stroke Res       Date:  2012-05-04       Impact factor: 6.829

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

Review 9.  Biomedical applications of sodium MRI in vivo.

Authors:  Guillaume Madelin; Ravinder R Regatte
Journal:  J Magn Reson Imaging       Date:  2013-05-30       Impact factor: 4.813

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  6 in total

1.  Tissue sodium concentration and sodium T1 mapping of the human brain at 3 T using a Variable Flip Angle method.

Authors:  Arthur Coste; Fawzi Boumezbeur; Alexandre Vignaud; Guillaume Madelin; Kathrin Reetz; Denis Le Bihan; Cécile Rabrait-Lerman; Sandro Romanzetti
Journal:  Magn Reson Imaging       Date:  2019-01-26       Impact factor: 2.546

2.  Quantitative Sodium (23Na) MRI in Pediatric Gliomas: Initial Experience.

Authors:  Aashim Bhatia; Vincent Kyu Lee; Yongxian Qian; Michael J Paldino; Rafael Ceschin; Jasmine Hect; James M Mountz; Dandan Sun; Gary Kohanbash; Ian F Pollack; Regina I Jakacki; Fernando Boada; Ashok Panigrahy
Journal:  Diagnostics (Basel)       Date:  2022-05-13

3.  Multiparametric classification of sub-acute ischemic stroke recovery with ultrafast diffusion, 23 Na, and MPIO-labeled stem cell MRI at 21.1 T.

Authors:  Avigdor Leftin; Jens T Rosenberg; Xuegang Yuan; Teng Ma; Samuel C Grant; Lucio Frydman
Journal:  NMR Biomed       Date:  2019-12-03       Impact factor: 4.044

4.  Investigating potentially salvageable penumbra tissue in an in vivo model of transient ischemic stroke using sodium, diffusion, and perfusion magnetic resonance imaging.

Authors:  Friedrich Wetterling; Eva Chatzikonstantinou; Laurent Tritschler; Stephen Meairs; Marc Fatar; Lothar R Schad; Saema Ansar
Journal:  BMC Neurosci       Date:  2016-12-07       Impact factor: 3.288

5.  Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain Lesions.

Authors:  Armin Biller; Isabella Pflugmann; Stephanie Badde; Ricarda Diem; Brigitte Wildemann; Armin M Nagel; J Jordan; Nadia Benkhedah; Jens Kleesiek
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

Review 6.  Neuroimaging as a Selection Tool and Endpoint in Clinical and Pre-clinical Trials.

Authors:  Keith W Muir; I Mhairi Macrae
Journal:  Transl Stroke Res       Date:  2016-08-20       Impact factor: 6.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.